Related Experiment Video
Updated: Apr 26, 2026
09:35
Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
12.8K
Hepatitis B virus drug resistance tools: one sequence, two predictions
Maria Neumann-Fraune1, Bastian Beggel, Rolf Kaiser
1Institute of Virology, University of Cologne, Cologne, Germany.
Intervirology
|July 19, 2014
Summary
Genotypic drug resistance testing is crucial for personalized hepatitis B virus (HBV) antiviral therapy. This review compares interpretation systems for HBV genotype analysis, aiding treatment decisions.
Area of Science:
- Virology
- Genetics
- Pharmacology
Background:
- Hepatitis B virus (HBV) drug resistance testing is essential for effective antiviral therapy.
- Phenotypic testing is labor-intensive, making genotypic methods vital for HBV management.
- Understanding resistance and immune/vaccine escape variants guides personalized treatment.
Purpose of the Study:
- To review the interpretation of HBV drug resistance genotypes.
- To compare available commercial and free HBV genotype interpretation systems.
- To highlight the role of genotypic analysis in personalized antiviral treatment for hepatitis B.
Main Methods:
- Analysis of HBV genome, focusing on overlapping open reading frames for HBsAg and RT.
- Standard Sanger sequencing (dye-dideoxynucleotide terminator system) for genetic information retrieval.
- Comparison of interpretation systems: TRUGENE, Abbott ViroScore, geno2pheno[HBV], and HIV-GRADE HBV tool.
Main Results:
- Genotypic methods are preferred over phenotypic testing for HBV resistance due to simplicity.
- Simultaneous analysis of two HBV genes is possible from a single genomic region.
- Various interpretation systems exist, offering different approaches to genotypic data analysis.
Conclusions:
- Genotypic interpretation systems are key tools for personalized antiviral therapy in hepatitis B.
- The choice of interpretation system depends on diagnostic needs and resource availability.
- Accurate genotype analysis supports optimized treatment strategies for HBV patients.
More Related Videos
Related Concept Videos
02:56Treatment Resistant Cancers
2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
01:25Hepatitis
78
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
78
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271